Biologics CDMO
ServiceContract manufacturing of clinical material and commercial drug substance for pharmaceutical companies in Korea and abroad.
FROM PUBLIC EVENTS · 2026-11-15
Late clinical · capacity Orders are growing as contract-manufacturing agreements with customers in Korea and abroad follow one another.
Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · BD & licensing
A biologics contract development and manufacturing organisation producing everything from clinical material to commercial drug substance.
Contract manufacturing of clinical material and commercial drug substance for pharmaceutical companies in Korea and abroad.
Signed its first CDMO agreement with a Japanese global pharmaceutical company.
Won a follow-on order to make clinical material for a Korean biosimilar customer.
Official role guide
Observed 2026-11-15
Information from a role guide does not establish a current vacancy.
A brief based on selected official material, not an exhaustive product or vacancy list.